Delayed systemic recurrence of uveal melanoma

por Kolandjian, Nathalie A., Wei, Caimiao, Patel, Sapna P., Richard, Jessie, Dett, Tina, Papadopoulos, Nicholas, Bedikian, Agop Y.
Publicado no Am J Clin Oncol (2013)

NRAS Mutation Status is an Independent Prognostic Factor in Metastatic Melanoma

por Jakob, John A., Bassett, Roland L., Ng, Chaan S., Curry, Jonathan L., Joseph, Richard W., Alvarado, Gladys C., Rohlfs, Michelle L., Richard, Jessie, Gershenwald, Jeffrey E., Hwu, Patrick, Kim, Kevin B., Lazar, Alexander J., Davies, Michael A.
Publicado em 2011

IMCT-07 THERAPEUTIC OUTCOMES OF INTRATHECAL INTERLEUKIN-2 IN METASTATIC MELANOMA PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD)

por Glitza, Isabella C., Rohlfs, Michelle, Bassett, Roland, John, Ida, Richard, Jessie, Iqbal, Masood, Bernzen, Theresa, Gerber, Donna, Lacey, Carol, Diab, Adi, Amaria, Roda, Woodman, Scott E, Patel, Sapna, Yee, Cassian, Hwu, Wen-Jen, McCutcheon, Ian E, Heimberger, Amy, Hwu, Patrick, Papadopoulos, Nicholas, Davies, Michael A
Publicado no Neuro Oncol (2015)

Intrathecal administration of tumor-infiltrating lymphocytes is well tolerated in a patient with leptomeningeal disease from metastatic melanoma: A case report

por Glitza, Isabella C., Haymaker, Cara, Bernatchez, Chantale, Vence, Luis, Rohlfs, Michelle, Richard, Jessie, Lacey, Carol, Mansaray, Rahmatu, Fulbright, Orenthial J., Ramachandran, Renjith, Toth, Christopher, Wardell, Seth, Patel, Sapna P., Woodman, Scott E., Hwu, Wen-Jen, Radvanyi, Laszlo G., Davies, Michael A., Papadopoulos, Nicholas E., Hwu, Patrick
Publicado no Cancer Immunol Res (2015)